Cladribine-based salvage regimen-induced deep remission of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukemia phase

Hematol Oncol. 2020 Apr;38(2):207-209. doi: 10.1002/hon.2683. Epub 2020 Jan 30.

[Article in German]

Authors

Han Yao¹, Peiyan Kong¹

Affiliation

¹ Department of Hematology, Army Medical University affiliated Xinqiao Hospital, Chongqing, China.

PMID: 31999842
DOI: 10.1002/hon.2683

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Blast Crisis / drug therapy*
Blast Crisis / pathology
Cladribine / administration & dosage
Cytarabine / administration & dosage
Dendritic Cells / drug effects*
Dendritic Cells / pathology
Doxorubicin / administration & dosage
Hematologic Neoplasms / drug therapy*
Hematologic Neoplasms / pathology
Humans
Male
Prognosis
Remission Induction
Salvage Therapy*

Substances

Cytarabine
Cladribine
Doxorubicin